Sirolimus (INN/USAN), also known as rapamycin, is a macrolide produced by the
bacterium Streptomyces hygroscopicus. It has immunosuppressant functions in ...
Sirolimus may increase the risk that you will develop an infection or cancer,
especially lymphoma (cancer of a part of the immune system) or skin cancer.
It is bioactive only when bound to immunophilins. Sirolimus is a potent
immunosuppressant and possesses both antifungal and antineoplastic
Find patient medical information for sirolimus oral on WebMD including its uses,
side effects and safety, interactions, pictures, warnings and user ratings.
Medscape - Kidney transplant dosing for Rapamune (sirolimus), frequency-
based adverse effects, comprehensive interactions, contraindications, pregnancy
When a patient receives an organ transplant, the body's white blood cells will try
to get rid of (reject) the transplanted organ. Sirolimus works by preventing the ...
Sirolimus (rapamycin), the latest one, is still being developed. It seems a very
promising immunosuppressive drug which could in future replace calcineurin ...
Sirolimus, rapamycin. Authoritative facts about the skin from DermNet New
Jul 23, 2015 ... FDA ALERT [07/14/2009]; Information for Healthcare Professionals: Sirolimus (
marketed as Rapamune) [ARCHIVED] FDA ALERT [06/11/2009] ...
sirolimus: A natural macrocyclic lactone produced by the bacterium Streptomyces
hygroscopicus, with immunosuppressant properties. In cells, sirolimus binds to ...